HIV Dermatology
Module Instructions
The following module contains hyperlinked
information which serves to offer more
information on topics you may or may not be
familiar with. We encourage that you read all
the hyperlinked information.
HIV Dermatology: Basic Facts
90% of patients with HIV have skin findings
At times, these skin findings can help in diagnosing HIV in a
patient
HIV causes the loss of helper T cells and this
immunodeficiency increases:
Skin infections
Inflammatory dermatoses (may seem counterintuitive but
HIV INCREASES immune activity of the skin!)
Neoplasms
Typically, ARV therapy improves skin conditions that
result from the loss of T cells
HIV Dermatology: Basic Facts
The skin serves as an excellent marker for CD4
count and state of the immune system
Patients with AIDS often have multiple skin
problems at presentation making a fully body
examination including the mouth important!
Some skin conditions may help diagnose HIV+
in individuals unaware of their HIV status
In herpes zoster (shingles) patients <50 yo, HIV
serology should be considered
Case 1
Case 1: History
HPI: 53 yo man presents with generalized
lymphadenopathy and diarrhea for the past month. He
also noticed that he has had lesions on his elbows and
knees.
PMH: none
All: none
Meds: none
FH: father with dandruff, mother with psoriasis and
atopic dermatitis
SH: homeless living in the city, reports IV drug use for
the past 5 years
Case 1: Exam
On exam, pt has scattered erythematous
plaques on his chest as well as scattered
erythematous plaques with overlying scale on
the legs bilaterally most prominent on the
anterior knees
Case 1: Labs
Given the patient’s generalized
lymphadenopathy, a HIV serum antibody was
drawn
The patient was found to be HIV+
Case 1: Question 1
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Case 1: Question 1
Answer: b
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Case 1: Explained
The patient has a clinical exam and history
consistent with psoriasis which is associated
with a CD4 count of 200-500. He also has
“dandruff” consistent with seborrheic dermatitis
Dermatologic Manifestations CD4 200-500
Seborrheic dermatitis
Psoriasis
Reactive arthritis
Atopic dermatitis
Herpes zoster
Acne Rosacea
Oral hairy leukoplakia
Onychomycosis
Warts
S. aureus folliculitis
Mucocutaneous candidiasis
HIV and CD4 Count
The typical skin findings of HIV are often CD4
count related. However it is not a definite
marker, many healthy individuals get conditions
listed previously.
The patient has generalized LA, diarrhea,
psoriasis and seborrheic dermatitis which are all
consistent with a CD4 count of 200-500.
Case 2
Case 2: History
HPI: 38 yo man with 5 yr history of HIV
presents with “bumps” behind his ear as well as
well as white spots on his tongue and mouth
PMH: HIV
All: none
Meds: none (not on ARV)
FH: non-remarkable
SH: lives in the city with his girlfriend
Case 2: Exam
On exam, pt has 5-10 <1cm pearly
umbilicated papules behind his right ear.
He also has multiple white cheesy papules
on the palate coalescing into plaques
Case 2: Question 1
What is the patient’s likely diagnosis(es)?
a. warts
b. molluscum contagiosum
c. oral candidiasis
d. basal cell carcinoma
Case 2: Question 1
Answer: b,c
What is the patient’s likely diagnosis(es)?
a. warts
b. molluscum contagiosum
c. oral candidiasis
d. basal cell carcinoma
Case 2: Question 2
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Case 2: Question 2
Answer: c
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Dermatologic Manifestations CD4 <200
Molluscum contagiosum
Bartonellosis (bacillary angiomatosis)
Systemic fungal infection
Mycobacterial infections
Also, skin becomes hyperactive at this stage
Eosinophilic folliculitis
Granuloma annulare
Drug reactions
Photodermatitis
Case 3
Case 3: History
55 yo man is admitted with numerous crusted lesions
all over his body and causing him significant pruritus
PMH: HIV for the past 9 years
All: none
Meds: none
FH: non-remarkable
SH: lives with his brother who has also been itching but
has not noticed any lesions
ROS: negative
Case 3: Exam
On exam, patient is noted to have diffuse
burrows throughout his body. He also has
large hyperkeratotic plaques with erosions
and ulcerations most severe on his buttock
and feet shown here
Case 3: Question 1
What is the most likely diagnosis?
a. crusted scabies
b. disseminated atopic dermatitis
c. disseminated psoriasis
d. disseminated herpes simplex
Case 3: Question 1
Answer: a
What is the most likely diagnosis?
a. crusted scabies
b. disseminated atopic dermatitis (would not
have burrows, unlikely to be as diffuse)
c. disseminated psoriasis (would not have burrows,
more typically plaques with scale)
d. disseminated herpes simplex (would not have
burrows, more vesicular with less scale)
Case 3: Question 2
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Case 3: Question 2
Answer: d
What is the patient’s likely CD4 count?
a. >500
b. 200-500
c. <200
d. <50
Dermatologic Manifestations CD4 <50
Refractory molluscum contagiosum
Chronic HSV
Chronic varicella zoster
Cutaneous acanthamebiasis
Chronic atypical mycobacterial infections
Crusted Scabies
Scabies
Eruption that results in pruritic papules and
burrows from the mite sacroptes scabiei
Typically spares the face and head except in
immunocompromised hosts
In immunocompromised or neurologically
impaired hosts it may become diffuse crusted
scabies
Similar but more diffuse papular eruption with
hyperkeratosis
Scabies Distribution
In crusted scabies, the
head and face are
involved as well as
the rest of the body.
The diagram to the
left is a distribution of
typical scabies.
Diagnosis can be
done by scraping on
of the lesions and
placing it in a KOH
or oil preparation to
visualize the mite.
http://www.stanford.edu/class/humbio103/ParaSites2005/Scabies/SCABIES.html
Scabies Treatment
In non-crusted scabies, permethrin 5% cream is rubbed into
the skin and washed off 8-10 hours later. This is repeated 1
week later
Ivermectin 200mg/kg can be used in addition at 2 wk
intervals for 2-3 doses but when used alone it is less
effective than topical treatment
NOT SAFE IN BABIES OR DURING PREGNANCY
For these patients, 6-10% sulfur can be used for 3 nights
Close contacts of any scabies patient should be
treated particularly in the case of crusted scabies
Crusted Scabies Treatment
Crusted scabies is far more difficult to treat as there are an
incredibly large number of mites.
Typically combination therapy is used in in crusted scabies
Ivermectin 200mg/kg given every 1-2 weeks up to 3-4
doses
Permethrin once a week for 6 weeks
Keratolytics and 40% urea for nail involvement
Remember to CLEAN CLOTHING AND BED LINENS
to avoid reinfestation!
Case 4
Case 4: History
HPI: 48 year old man presents with purple spots on his
body that he had not noticed before. They are not
causing him pain or pruritus
PMH: HIV+ for 12 years
All: none
Meds: none
FH: non-remarkable
SH: non-remarkable
ROS: negative
Case 4: Exam
On exam, the patient has
scattered purple macules, plaques,
and nodules of varying sizes and
shapes, mainly found on the
truck and face
Nodule Macule Plaque
Case 4: Question 1
What is the most likely diagnosis?
a. thrombotic thrombocytopenia purpura
b. Kaposi’s sarcoma
c. melanoma
d. urticaria
Case 4: Question 1
Answer: b
What is the most likely diagnosis?
a. thrombotic thrombocytopenia purpura
b. Kaposi’s sarcoma
c. melanoma
d. urticaria
Kaposi’s Sarcoma
Kaposi’s sarcoma is a cutaneous malignancy which is
found far more commonly in HIV+ individuals
Manifestation in HIV+ patients is clinically different than in
HIV- patients
Caused by HHV-8 virus
Clinically it presents with red or purple macules and
progresses into purple plaques, tumors, nodules
Most commonly found on the hard palate, trunk, penis, lower
legs, soles
Edema may be present with lower leg lesions
Kaposi’s Sarcoma
Diagnosis is confirmed with skin biopsy and is
used to differentiate Kaposi’s Sarcoma from
other diagnoses
Kaposi’s Sarcoma
Treatment depends on the stage in HIV related
cases
Mild to moderate disease with <50 lesions can
usually be treated with 6 months of ARV therapy
50% resolution results from this treatment
For individual lesions, vinblastine injection or
cryotherapy is appropriate
For systemic manifestations, systemic
chemotherapy becomes necessary
Other Malignancy in HIV
HIV+ patients have a higher incidence of basal cell
carcinoma than non HIV- patients but the BCC
behavior is the same
Squamous cell carcinoma in sun exposed areas is more
aggressive in HIV+ patients making COMPLETE
resection important
Melanoma prevalence is unknown but may be higher in
HIV+ patients and behavior is more aggressive
The progression of HPV to neoplasm is accelerated in
HIV, including cervical, anal, and penile cancer
Extranodal B cell and T cell lymphoma is associated
with HIV immunosuppression
Case 4: Continued
What if a patient instead presented with the
following problem: